Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Argos Therapeutics Company Profile (NASDAQ:ARGS)

Consensus Ratings for Argos Therapeutics (NASDAQ:ARGS) (?)
Ratings Breakdown: 1 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $12.67 (38.58% upside)

Analysts' Ratings History for Argos Therapeutics (NASDAQ:ARGS)
Show:
DateFirmActionRatingPrice TargetDetailsShare
2/25/2015MLV & Co Initiated CoverageBuy$13.00ViewTweet This Rating  Share This Rating on StockTwits
8/27/2014ZacksDowngradeNeutral$9.00ViewTweet This Rating  Share This Rating on StockTwits
8/19/2014Stifel NicolausInitiated CoverageBuy$16.00ViewTweet This Rating  Share This Rating on StockTwits
3/4/2014Stifel NicolausInitiated CoverageBuy -> Buy$16.00ViewTweet This Rating  Share This Rating on StockTwits
3/4/2014Piper JaffrayInitiated CoverageOverweight$18.00ViewTweet This Rating  Share This Rating on StockTwits
3/4/2014JMP SecuritiesInitiated CoverageOutperform$17.00ViewTweet This Rating  Share This Rating on StockTwits
3/4/2014Needham & Company LLCInitiated CoverageBuy$17.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 3/5/2013 forward)